Berry: The Health Effect of Diet Rich in Nordic Berries

Sponsor
Marjukka Kolehmainen (Other)
Overall Status
Completed
CT.gov ID
NCT01414647
Collaborator
VTT Technical Research Centre, Finland (Other)
56
1
3
49.9
1.1

Study Details

Study Description

Brief Summary

Dietary polyphenols might have beneficial effects on glucose and lipid metabolism based on the studies made in animals or cell cultures. The findings regarding the possible decrease of low-grade inflammation are existing also in humans. Low-grade inflammation has been suggested to be a mechanistic link between obesity and its consequences on cardiometabolic health. The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: 300 g of strawberry, raspberry and cloudberry
  • Dietary Supplement: 400 g of bilberry
  • Other: Control diet
N/A

Detailed Description

Berries are traditionally an important part of the Nordic diet. About 50 different berries are grown in the northern region, and about half of them are edible. Phenolic compounds are one of the most diverse group of secondary metabolites present in edible plants, and berries are especially rich in them. Flavonoids, phenolic acids, lignans and complex phenolic polymers (polymeric tannins) are typical for berries. Phenolic compounds are reported to have a variety of beneficial biological properties. They are potent antioxidants, and exhibit various other physiological activities including anti-inflammatory, antimicrobial, antiallergic, anticarcinogenic and antihypertensive activities. Epidemiological studies indicate that diet rich in phenolic compound correlates with lower risk of cancer and cardiovascular disease.

The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers and gene expression profile in peripheral blood mononuclear cells (PBMCs) in subjects with features of metabolic syndrome.

Randomized, controlled clinical intervention including 4 wk run-in period, 8 wk dietary intervention and 4 wk recovery period was conducted.

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Effect of Diet Rich in Nordic Berries on Gut Microbiota, Glucose and Lipid Metabolism and Metabolism on Fenolic Compounds
Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Dec 1, 2006
Actual Study Completion Date :
Mar 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: SRC

Strawberry, raspberry and cloudberry intervention for 8 weeks

Dietary Supplement: 300 g of strawberry, raspberry and cloudberry
100 g of strawberry puree, 100 g of frozen raspberries and 100 g frozen cloudberries were concumed daily for 8 weeks. Bilberry consumption was restricted.

Experimental: BB

Bilberry intervention for 8 weeks

Dietary Supplement: 400 g of bilberry
Equivalent amount to 400 g of fresh bilberries were consumed as 40 g of dried bilberries and as 200 g of frozen bilberries. Restriction of use of strawberries, raspberries and cloudberries were set.

Experimental: C

Control diet with restricted berry consumption

Other: Control diet
Control diet, ie. habitual diet with restriction of berry consumption was consumed for eight weeks
Other Names:
  • Diet with restricted consumption of berries.
  • Outcome Measures

    Primary Outcome Measures

    1. Glucose level [week 8]

      Fasting glucose level oral glucose tolerance status at study week 8

    2. Cholesterol level [week 8]

      total, HDL and LDL cholesterol level at the study week 8

    3. Inflammation markers [week 8]

      Various inflammation markers were measured at the study week 8

    Secondary Outcome Measures

    1. Markers of sterol metabolism [week 8]

      Markers of cholesterol absorption and synthesis were measured

    2. gene expression in PBMCs [study week 8]

      Global gene expression analyses in peripheral mononuclear cells (PBMC)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • overweight (BMI 26-39 kg/m2), and two of the following:

    • elevated fasting plasma glucose in the absence of diabetes (5.6-6.9 mmol/l)

    • abnormal serum lipid concentration: fasting serum triglyceride concentration >1.7 mmol/L, fasting serum HDL cholesterol <1.0 mmol/L (males) or <1.3 mmol/L (females))

    • waist circumference >102 cm (males) or >88 cm (females)

    • blood pressure >130/85 mmHg

    Exclusion Criteria:
    • chronic diseases

    • use of lipid lowering medication

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Eastern Finland, Dpet of Public Health and Clinical Nutrition Kuopio Finland FIN-70211

    Sponsors and Collaborators

    • Marjukka Kolehmainen
    • VTT Technical Research Centre, Finland

    Investigators

    • Principal Investigator: Riitta Törrönen, Adjunct Professor, University of Eastern Finland

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marjukka Kolehmainen, Senior scientist, University of Eastern Finland
    ClinicalTrials.gov Identifier:
    NCT01414647
    Other Study ID Numbers:
    • 124//2005
    • 40361/05
    First Posted:
    Aug 11, 2011
    Last Update Posted:
    May 17, 2018
    Last Verified:
    May 1, 2018
    Keywords provided by Marjukka Kolehmainen, Senior scientist, University of Eastern Finland
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 17, 2018